Immunohistochemical staining of CD8 on the tumor sections showed that the combinatorial treatment greatly enhanced CD8+ T cell tumor infiltration (Figure 7K,L), suggesting an enhanced anti‐tumor immunity effect by combining the Glu‐GSH flux inhibitor and immune checkpoint inhibitor. The gene discussed is CD8A; the disease is neoplasm.